Remote controlled transdermal medication delivery device
First Claim
1. A transdermal medication delivery device for remote controlled administration of a medication for absorption through the skin of a patient, said device comprising:
- a chamber containing said medication;
a valve having a valve inlet in fluid communication with said chamber and having a valve outlet;
a medication delivery component in fluid communication with said valve outlet and having a surface adapted to be in contact with said skin of said patient when in use;
a controller for controlling a flow of said medication through said valve; and
a wireless communication interface in communication with said controller for receiving a medication control message from a remote location, said medication control message instructing said controller to regulate said valve to adjust said flow of said medication from said chamber to said surface of said medication delivery component.
1 Assignment
0 Petitions
Accused Products
Abstract
A transdermal medication delivery device (20) for the remote controlled administration of medications (68, 70, 72) for absorption through the skin of a patient (22) includes a tubes (62) containing the medications (68, 70, 72). Tubes (62) are in fluid communication with valve inlets (76, 82, 88) of valves (74, 80, 86) formed on a micro-electro-mechanical-system-based (MEMS-based) valve chip (64, 162). A medication delivery component (26, 176) in fluid communication with valve outlets (78, 84, 90) of valves (74, 80, 86) has a surface (66, 178) adapted to be in contact with the skin of the patient (22) when in use. A controller (92) is configured to control a flow of the medications (68, 70, 72) through the valves (74, 80, 86), and a wireless communication interface (94), in communication with the controller (92), is configured to receive a medication control message (96) from a remote location (32). The medication control message (96) instructs the controller (92) to regulate the valves (74, 80, 86) to adjust the flow of the medications (68, 70, 72) from the tubes (62) to the surface (66, 188) of the medication delivery component (26, 176).
-
Citations
23 Claims
-
1. A transdermal medication delivery device for remote controlled administration of a medication for absorption through the skin of a patient, said device comprising:
-
a chamber containing said medication;
a valve having a valve inlet in fluid communication with said chamber and having a valve outlet;
a medication delivery component in fluid communication with said valve outlet and having a surface adapted to be in contact with said skin of said patient when in use;
a controller for controlling a flow of said medication through said valve; and
a wireless communication interface in communication with said controller for receiving a medication control message from a remote location, said medication control message instructing said controller to regulate said valve to adjust said flow of said medication from said chamber to said surface of said medication delivery component. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 17, 18, 19)
-
-
16. A device as claimed in claim 16 wherein said controller generates a fluid level message in response to said fluid level signal, and said wireless communication interface communicates said fluid level message to said remote location.
-
20. A transdermal medication delivery device for remote controlled administration of medications for absorption through the skin of a patient, said device comprising:
-
a first chamber containing a first one of said medications and having a first self-sealing cap;
a second chamber containing a second one of said medications and having a second self-sealing cap;
a housing including a first recessed port in which said first chamber is positioned, a first hollow needle having a first end and a second end, said first end projecting into said first recessed port to pierce said self-sealing cap of said first chamber, and said housing further including a second recessed port in which said second chamber is positioned, a second hollow needle having a third end and a fourth end, said third end projecting into said second recessed port to pierce said self-sealing cap of said second chamber;
a first valve having a first valve inlet and a first valve outlet, said first valve inlet being in fluid communication with said second end of said first hollow needle;
a second valve having a second valve inlet and a second valve outlet, said second valve inlet being in fluid communication with said fourth end of said second hollow needle;
a medication delivery component in fluid communication with each of said first and second valve outlets and having a surface adapted to be in contact with said skin of said patient when in use;
a controller for controlling a flow of said first and second medications through each of said first and second valves; and
a wireless communication interface in communication with said controller for receiving a medication control message from a remote location, said medication control message instructing said controller to regulate said first and second valves to adjust said flow of said first medication from said first chamber to said surface of said medication delivery component and to adjust said flow of said second medication from said second tube to said surface of said medication delivery component. - View Dependent Claims (21, 22)
-
-
23. A transdermal medication delivery device for remote controlled administration of a medication for absorption through the skin of a patient, said device comprising:
-
a chamber containing said medication;
a valve having a valve inlet and a valve outlet, said valve inlet being in fluid communication with said chamber;
a medication delivery component in fluid communication with said valve outlet and having a surface adapted to be in contact with said skin of said patient when in use;
a controller for controlling a flow of said medication through said valve;
a fluid level sensor proximate said chamber for providing a fluid level signal to said controller indicative of a fluid level of said medication in said chamber, said controller generating a fluid level message corresponding to said fluid level signal;
a patient status monitor integral to a housing of said device and in communication with said controller for monitoring vital signs of said patient; and
a wireless communication interface in communication with said controller for communicating said fluid level message and said vital signs to said remote location, and for receiving a medication control message from a remote location, said medication control message instructing said controller to regulate said valve to adjust said flow of said medication from said chamber to said surface of said medication delivery component.
-
Specification